August 15, 2024
Alnylam Named a Humankind 100 Company for the 3rd Year in a Row
Alnylam has been named to the HumanKind 100 list for the 2nd year in a row and we’re pleased to have moved up in the rankings from #97 in 2022 to #76 in 2023.
Read More ›
June 23, 2023
Alnylam in the Community: CASPAR Partnership Highlight
Alnylam has partnered with community organization CASPAR (Cambridge And Somerville Programs for Addiction Recovery) for many years.
Read More ›
March 16, 2022
Alnylam Publishes 2021 Corporate Responsibility Report
We're committed to taking bold actions that improve the health of humanity. Our 2021 Corporate Responsibility Report provides details on our progress...
Read More ›
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site